Exact Mass: 578.3666

Asparagoside A

C33H54O8 (578.3818)

Melongoside A is found in fruits. Melongoside A is a constituent of aubergine (Solanum melongena).

Prednisolone 21-all-cis-farnesylate

C36H50O6 (578.3607)

Okenone

C41H54O2 (578.4124)

D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

Timosaponin A-I

C33H54O8 (578.3818)

Anhydroamarouciaxanthin B

C40H50O3 (578.376)

Anhydroamarouciaxanthin B is found in blue mussel. Anhydroamarouciaxanthin B is a constituent of Mytilus edulis (blue mussel). Constituent of Mytilus edulis (blue mussel). Anhydroamarouciaxanthin B is found in blue mussel and mollusks.

PA(10:0/17:0)

C30H59O8P (578.3947)

PA(10:0/17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/17:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of margaric acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(8:0/19:0)

C30H59O8P (578.3947)

PA(8:0/19:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/19:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of nonadecylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(10:0/a-17:0)

C30H59O8P (578.3947)

PA(10:0/a-17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/a-17:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of anteisoheptadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(10:0/i-17:0)

C30H59O8P (578.3947)

PA(10:0/i-17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/i-17:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of isoheptadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(8:0/i-19:0)

C30H59O8P (578.3947)

PA(8:0/i-19:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/i-19:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of isononadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(a-13:0/i-14:0)

C30H59O8P (578.3947)

PA(a-13:0/i-14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-13:0/i-14:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of isotetradecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-12:0/a-15:0)

C30H59O8P (578.3947)

PA(i-12:0/a-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/a-15:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of anteisopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-12:0/i-15:0)

C30H59O8P (578.3947)

PA(i-12:0/i-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/i-15:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of isopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-13:0/i-14:0)

C30H59O8P (578.3947)

PA(i-13:0/i-14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-13:0/i-14:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of isotetradecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-14:0/a-13:0)

C30H59O8P (578.3947)

PA(i-14:0/a-13:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-14:0/a-13:0), in particular, consists of one chain of isotetradecanoic acid at the C-1 position and one chain of anteisotridecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-14:0/i-13:0)

C30H59O8P (578.3947)

PA(i-14:0/i-13:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-14:0/i-13:0), in particular, consists of one chain of isotetradecanoic acid at the C-1 position and one chain of isotridecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

Chenodeoxycholyltryptophan

C35H50N2O5 (578.372)

Chenodeoxycholyltryptophan belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Chenodeoxycholyltryptophan consists of the bile acid chenodeoxycholic acid conjugated to the amino acid Tryptophan conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Chenodeoxycholyltryptophan, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Chenodeoxycholyltryptophan appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

Deoxycholyltryptophan

C35H50N2O5 (578.372)

Deoxycholyltryptophan belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Deoxycholyltryptophan consists of the bile acid deoxycholic acid conjugated to the amino acid Tryptophan conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Deoxycholyltryptophan, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Deoxycholyltryptophan appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

DG(10:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C33H54O8 (578.3818)

DG(10:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/10:0/0:0)

C33H54O8 (578.3818)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C33H54O8 (578.3818)

DG(10:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/10:0)

C33H54O8 (578.3818)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Timosaponin A1

C33H54O8 (578.3818)

Timosaponin A1 is a natural product found in Anemarrhena asphodeloides with data available. Timosaponin A1 is a coprostane type steroidal saponin isolated from Rhizoma Anemarrhenae. Timosaponin A1 is a coprostane type steroidal saponin isolated from Rhizoma Anemarrhenae.

Ulmicin B

C37H54O5 (578.3971)

Oleoyl neocryptotanshinone

C37H54O5 (578.3971)

A diterpenoid with a fatty acyl side chain isolated from Salvia miltiorrhiza and has been shown to inhibit platelet aggregation induced by arachidonic acid.

Revandchinone 3

C37H54O5 (578.3971)

gagunin G

C32H50O9 (578.3455)

Deacetyltomentoside I

C33H54O8 (578.3818)

Echinophyllin E

C34H46N2O6 (578.3356)

Fungicide K 99-5278C

C33H54O8 (578.3818)

FD 891

C33H54O8 (578.3818)

Phoeniconone

C40H50O3 (578.376)

Torularhodin, methyl ester

C41H54O2 (578.4124)

Hugonone B

C36H50O6 (578.3607)

gagunin L

C32H50O9 (578.3455)

gagunin N

C32H50O9 (578.3455)

Lanceolitol A5

C29H54O11 (578.3666)

Lanceolitol A6

C29H54O11 (578.3666)

SCHEMBL8346686

C30H58O10 (578.403)

4-Ketoalloxanthin

C40H50O3 (578.376)

7-hydroxy-23,24-dihydrocucurbitacin F 25-O-acetate|Hemslecin G

C32H50O9 (578.3455)

(22S)-cholesta-5,24-diene-3beta,11alpha,16beta,22-tetrol 16-O-alpha-L-rhamnopyranoside|(22S)-Cholesta-5,24-diene-3??,11??,16??,22-tetrol 16-O-??-L-rhamnopyranoside

C33H54O8 (578.3818)

6-hydroxymanzamine E

C36H42N4O3 (578.3257)

Roserythrin

C39H46O4 (578.3396)

C37H54O5

C37H54O5 (578.3971)

Hermonionic acid

C35H46O7 (578.3243)

C32H50O9

C32H50O9 (578.3455)

(+)-buxalongifolamidine|Buxalongifolamidine

C35H50N2O5 (578.372)

6alpha-O-beta-D-quinovopyranosyl-(25R)-5alpha-spirostan-3beta-ol|6alpha-O-beta-quinovopyranosyl-(25R)-5alpha-spirostan-3beta-ol|saponin Sc-4|SC-4

C33H54O8 (578.3818)

nostoginin BN578

C30H50N4O7 (578.3679)

Sundaicumone A

C32H50O9 (578.3455)

cholestane-1beta,3beta,5alpha,6beta-tetraol 1,3,6-triacetate

C33H54O8 (578.3818)

tulearin B

C32H54N2O7 (578.3931)

(7S,8R,8R,4S,5S,7S,10S)-9-O-(11-hydroxyeudesman-4-yl)-dihydrosesamin

C35H46O7 (578.3243)

echinophyllin B

C34H46N2O6 (578.3356)

Anthogorgiene J

C42H42O2 (578.3185)

3beta,21alpha,24-trihydroxyserrat-14-en-3-(4-hydroxybenzoate)

C37H54O5 (578.3971)

3-O-benzoylpluricostatic acid|3beta-benzoyloxy-2alpha-hydroxy-D:A-friedoolean-28-oic acid

C37H54O5 (578.3971)

(25S)-3beta-hydroxy-5alpha-spirostan-6alpha-yl-O-beta-D-xylopyranoside

C33H54O8 (578.3818)

3beta,21beta,24-trihydroxyserrat-14-en-24-(4-hydroxybenzoate)

C37H54O5 (578.3971)

(-)-12,34-oxamanzamine F

C36H42N4O3 (578.3257)

formosalide A

C32H50O9 (578.3455)

12,34-oxa-6-hydroxymanzamine E

C36H42N4O3 (578.3257)

3,4,4-Trioxo-beta-carotin

C40H50O3 (578.376)

(+)-buxoxybenzamine|(-)-buxoxybenzamine

C35H50N2O5 (578.372)

buxafuranamide

C35H50N2O5 (578.372)

8alpha,9alpha-Epoxide,10beta-hydroxy,25-Me ether-Antibiotic FD 892|FD-891

C33H54O8 (578.3818)

3beta-vanilloyloxy-stigmast-5-ene-7-one

C37H54O5 (578.3971)

Manzamine F

C36H42N4O3 (578.3257)

Gly Phe Ile Ser Arg

C26H42N8O7 (578.3176)

Tyr Gln Ile Arg

C26H42N8O7 (578.3176)

C32H50O9_beta-D-Xylopyranoside, 3,17-dihydroxyspirost-5-en-1-yl

C32H50O9 (578.3455)

putative tryptophane conjugated chenodeoxycholic acid

C35H50N2O5 (578.372)

putative tryptophane conjugated chenodeoxycholic acid (clustered spectrum)

C35H50N2O5 (578.372)

Tryptophane chenodeoxycholic acid

C35H50N2O5 (578.372)

Glu Phe Lys Arg

C26H42N8O7 (578.3176)

Glu Phe Arg Lys

C26H42N8O7 (578.3176)

Glu Lys Phe Arg

C26H42N8O7 (578.3176)

Glu Lys Arg Phe

C26H42N8O7 (578.3176)

Glu Arg Phe Lys

C26H42N8O7 (578.3176)

Glu Arg Lys Phe

C26H42N8O7 (578.3176)

Phe Glu Lys Arg

C26H42N8O7 (578.3176)

Phe Glu Arg Lys

C26H42N8O7 (578.3176)

Phe Lys Glu Arg

C26H42N8O7 (578.3176)

Phe Lys Arg Glu

C26H42N8O7 (578.3176)

Phe Lys Val Trp

C31H42N6O5 (578.3217)

Phe Lys Trp Val

C31H42N6O5 (578.3217)

Phe Arg Glu Lys

C26H42N8O7 (578.3176)

Phe Arg Lys Glu

C26H42N8O7 (578.3176)

Phe Arg Arg Thr

C25H42N10O6 (578.3289)

Phe Arg Thr Arg

C25H42N10O6 (578.3289)

Phe Thr Arg Arg

C25H42N10O6 (578.3289)

Phe Val Lys Trp

C31H42N6O5 (578.3217)

Phe Val Trp Lys

C31H42N6O5 (578.3217)

Phe Trp Lys Val

C31H42N6O5 (578.3217)

Phe Trp Val Lys

C31H42N6O5 (578.3217)

Ile Lys Arg Tyr

C27H46N8O6 (578.354)

Ile Lys Tyr Arg

C27H46N8O6 (578.354)

Ile Gln Arg Tyr

C26H42N8O7 (578.3176)

Ile Gln Tyr Arg

C26H42N8O7 (578.3176)

Ile Arg Lys Tyr

C27H46N8O6 (578.354)

Ile Arg Gln Tyr

C26H42N8O7 (578.3176)

Ile Arg Tyr Lys

C27H46N8O6 (578.354)

Ile Arg Tyr Gln

C26H42N8O7 (578.3176)

Ile Tyr Lys Arg

C27H46N8O6 (578.354)

Ile Tyr Gln Arg

C26H42N8O7 (578.3176)

Ile Tyr Arg Lys

C27H46N8O6 (578.354)

Ile Tyr Arg Gln

C26H42N8O7 (578.3176)

Lys Glu Phe Arg

C26H42N8O7 (578.3176)

Lys Glu Arg Phe

C26H42N8O7 (578.3176)

Lys Phe Glu Arg

C26H42N8O7 (578.3176)

Lys Phe Arg Glu

C26H42N8O7 (578.3176)

Lys Phe Val Trp

C31H42N6O5 (578.3217)

Lys Phe Trp Val

C31H42N6O5 (578.3217)

Lys Ile Arg Tyr

C27H46N8O6 (578.354)

Lys Ile Tyr Arg

C27H46N8O6 (578.354)

Lys Leu Arg Tyr

C27H46N8O6 (578.354)

Lys Leu Tyr Arg

C27H46N8O6 (578.354)

Lys Arg Glu Phe

C26H42N8O7 (578.3176)

Lys Arg Phe Glu

C26H42N8O7 (578.3176)

Lys Arg Ile Tyr

C27H46N8O6 (578.354)

Lys Arg Leu Tyr

C27H46N8O6 (578.354)

Lys Arg Tyr Ile

C27H46N8O6 (578.354)

Lys Arg Tyr Leu

C27H46N8O6 (578.354)

Lys Val Phe Trp

C31H42N6O5 (578.3217)

Lys Val Trp Phe

C31H42N6O5 (578.3217)

Lys Trp Phe Val

C31H42N6O5 (578.3217)

Lys Trp Val Phe

C31H42N6O5 (578.3217)

Lys Tyr Ile Arg

C27H46N8O6 (578.354)

Lys Tyr Leu Arg

C27H46N8O6 (578.354)

Lys Tyr Arg Ile

C27H46N8O6 (578.354)

Lys Tyr Arg Leu

C27H46N8O6 (578.354)

Leu Lys Arg Tyr

C27H46N8O6 (578.354)

Leu Lys Tyr Arg

C27H46N8O6 (578.354)

Leu Gln Arg Tyr

C26H42N8O7 (578.3176)

Leu Gln Tyr Arg

C26H42N8O7 (578.3176)

Leu Arg Lys Tyr

C27H46N8O6 (578.354)

Leu Arg Gln Tyr

C26H42N8O7 (578.3176)

Leu Arg Tyr Lys

C27H46N8O6 (578.354)

Leu Arg Tyr Gln

C26H42N8O7 (578.3176)

Leu Tyr Lys Arg

C27H46N8O6 (578.354)

Leu Tyr Gln Arg

C26H42N8O7 (578.3176)

Leu Tyr Arg Lys

C27H46N8O6 (578.354)

Leu Tyr Arg Gln

C26H42N8O7 (578.3176)

Gln Ile Arg Tyr

C26H42N8O7 (578.3176)

Gln Ile Tyr Arg

C26H42N8O7 (578.3176)

Gln Leu Arg Tyr

C26H42N8O7 (578.3176)

Gln Leu Tyr Arg

C26H42N8O7 (578.3176)

Gln Arg Ile Tyr

C26H42N8O7 (578.3176)

Gln Arg Leu Tyr

C26H42N8O7 (578.3176)

Gln Arg Tyr Ile

C26H42N8O7 (578.3176)

Gln Arg Tyr Leu

C26H42N8O7 (578.3176)

Gln Tyr Ile Arg

C26H42N8O7 (578.3176)

Gln Tyr Leu Arg

C26H42N8O7 (578.3176)

Gln Tyr Arg Ile

C26H42N8O7 (578.3176)

Gln Tyr Arg Leu

C26H42N8O7 (578.3176)

Arg Glu Phe Lys

C26H42N8O7 (578.3176)

Arg Glu Lys Phe

C26H42N8O7 (578.3176)

Arg Phe Glu Lys

C26H42N8O7 (578.3176)

Arg Phe Lys Glu

C26H42N8O7 (578.3176)

Arg Phe Arg Thr

C25H42N10O6 (578.3289)

Arg Phe Thr Arg

C25H42N10O6 (578.3289)

Arg Ile Lys Tyr

C27H46N8O6 (578.354)

Arg Ile Gln Tyr

C26H42N8O7 (578.3176)

Arg Ile Tyr Lys

C27H46N8O6 (578.354)

Arg Ile Tyr Gln

C26H42N8O7 (578.3176)

Arg Lys Glu Phe

C26H42N8O7 (578.3176)

Arg Lys Phe Glu

C26H42N8O7 (578.3176)

Arg Lys Ile Tyr

C27H46N8O6 (578.354)

Arg Lys Leu Tyr

C27H46N8O6 (578.354)

Arg Lys Tyr Ile

C27H46N8O6 (578.354)

Arg Lys Tyr Leu

C27H46N8O6 (578.354)

Arg Leu Lys Tyr

C27H46N8O6 (578.354)

Arg Leu Gln Tyr

C26H42N8O7 (578.3176)

Arg Leu Tyr Lys

C27H46N8O6 (578.354)

Arg Leu Tyr Gln

C26H42N8O7 (578.3176)

Arg Gln Ile Tyr

C26H42N8O7 (578.3176)

Arg Gln Leu Tyr

C26H42N8O7 (578.3176)

Arg Gln Tyr Ile

C26H42N8O7 (578.3176)

Arg Gln Tyr Leu

C26H42N8O7 (578.3176)

Arg Arg Phe Thr

C25H42N10O6 (578.3289)

Arg Arg Thr Phe

C25H42N10O6 (578.3289)

Arg Thr Phe Arg

C25H42N10O6 (578.3289)

Arg Thr Arg Phe

C25H42N10O6 (578.3289)

Arg Tyr Ile Lys

C27H46N8O6 (578.354)

Arg Tyr Ile Gln

C26H42N8O7 (578.3176)

Arg Tyr Lys Ile

C27H46N8O6 (578.354)

Arg Tyr Lys Leu

C27H46N8O6 (578.354)

Arg Tyr Leu Lys

C27H46N8O6 (578.354)

Arg Tyr Leu Gln

C26H42N8O7 (578.3176)

Arg Tyr Gln Ile

C26H42N8O7 (578.3176)

Arg Tyr Gln Leu

C26H42N8O7 (578.3176)

Thr Phe Arg Arg

C25H42N10O6 (578.3289)

Thr Arg Phe Arg

C25H42N10O6 (578.3289)

Thr Arg Arg Phe

C25H42N10O6 (578.3289)

Val Phe Lys Trp

C31H42N6O5 (578.3217)

Val Phe Trp Lys

C31H42N6O5 (578.3217)

Val Lys Phe Trp

C31H42N6O5 (578.3217)

Val Lys Trp Phe

C31H42N6O5 (578.3217)

Val Trp Phe Lys

C31H42N6O5 (578.3217)

Val Trp Lys Phe

C31H42N6O5 (578.3217)

Trp Phe Lys Val

C31H42N6O5 (578.3217)

Trp Phe Val Lys

C31H42N6O5 (578.3217)

Trp Lys Phe Val

C31H42N6O5 (578.3217)

Trp Lys Val Phe

C31H42N6O5 (578.3217)

Trp Val Phe Lys

C31H42N6O5 (578.3217)

Trp Val Lys Phe

C31H42N6O5 (578.3217)

Tyr Ile Lys Arg

C27H46N8O6 (578.354)

Tyr Ile Gln Arg

C26H42N8O7 (578.3176)

Tyr Ile Arg Lys

C27H46N8O6 (578.354)

Tyr Ile Arg Gln

C26H42N8O7 (578.3176)

Tyr Lys Ile Arg

C27H46N8O6 (578.354)

Tyr Lys Leu Arg

C27H46N8O6 (578.354)

Tyr Lys Arg Ile

C27H46N8O6 (578.354)

Tyr Lys Arg Leu

C27H46N8O6 (578.354)

Tyr Leu Lys Arg

C27H46N8O6 (578.354)

Tyr Leu Gln Arg

C26H42N8O7 (578.3176)

Tyr Leu Arg Lys

C27H46N8O6 (578.354)

Tyr Leu Arg Gln

C26H42N8O7 (578.3176)

Tyr Gln Leu Arg

C26H42N8O7 (578.3176)

Tyr Gln Arg Ile

C26H42N8O7 (578.3176)

Tyr Gln Arg Leu

C26H42N8O7 (578.3176)

Tyr Arg Ile Lys

C27H46N8O6 (578.354)

Tyr Arg Ile Gln

C26H42N8O7 (578.3176)

Tyr Arg Lys Ile

C27H46N8O6 (578.354)

Tyr Arg Lys Leu

C27H46N8O6 (578.354)

Tyr Arg Leu Lys

C27H46N8O6 (578.354)

Tyr Arg Leu Gln

C26H42N8O7 (578.3176)

Tyr Arg Gln Ile

C26H42N8O7 (578.3176)

Tyr Arg Gln Leu

C26H42N8O7 (578.3176)

GFISR

C26H42N8O7 (578.3176)

1,25-Dihydroxyvitamin D3 3-glycoside

C33H54O8 (578.3818)

1-NBD-decanoyl-2-decanoyl-sn-Glycerol

C29H46N4O8 (578.3315)

PA(12:0/15:0)

C30H59O8P (578.3947)

PA(13:0/14:0)

C30H59O8P (578.3947)

PA(14:0/13:0)

C30H59O8P (578.3947)

PA(15:0/12:0)

C30H59O8P (578.3947)

Pandaroside D

C33H54O8 (578.3818)

Asparagoside A

C33H54O8 (578.3818)

Isolated from rhizomes of Mexican sarsaparilla (Smilax aristolochiaefolia) and from asparagus (Asparagus officinalis) root. Asparagoside A is found in asparagus, herbs and spices, and green vegetables.

Anhydroamarouciaxanthin B

C40H50O3 (578.376)

PA 27:0

C30H59O8P (578.3947)

Cyathsterone A

C33H54O8 (578.3818)

Cyathsterone B

C33H54O8 (578.3818)

(25S)-5beta-spirostan-3beta-yl beta-D-glucoside

C33H54O8 (578.3818)

3beta,15alpha,16alpha,24alpha-tetrahydroxy25,26,27-trinor-16,24-cyclo-cycloartane-23-one-3-O-beta-D-xylopyranoside

C32H50O9 (578.3455)

Gelliodenone

C40H50O3 (578.376)

Hydroxyclathriaxanthin

C40H50O3 (578.376)

Didehydrotrikentriorhodin

C40H50O3 (578.376)

1,1-DIBUTYL-3,3,3,3-TETRAMETHYL-INDADICARBOCYANINE PERCHLORATE

C33H55ClN2O4 (578.385)

Palmitoyl oligopeptide

C30H54N6O5 (578.4155)

Prednisolone Farnesylate

C36H50O6 (578.3607)

Melongoside A

C33H54O8 (578.3818)

Constituent of aubergine (Solanum melongena). Melongoside A is found in fruits and eggplant.

O-glucosyl-tomatidine

C33H56NO7+ (578.4057)

DG(10:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C33H54O8 (578.3818)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/10:0/0:0)

C33H54O8 (578.3818)

DG(10:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C33H54O8 (578.3818)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/10:0)

C33H54O8 (578.3818)

2-[[(2R)-3-acetyloxy-2-[8-[3-[(Z)-oct-2-enyl]oxiran-2-yl]octanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H53NO9P+ (578.3458)

2-[[(2R)-2-acetyloxy-3-[8-[3-[(Z)-oct-2-enyl]oxiran-2-yl]octanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H53NO9P+ (578.3458)

2-[[(2R)-3-acetyloxy-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H53NO9P+ (578.3458)

2-[[(2R)-2-acetyloxy-3-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H53NO9P+ (578.3458)

sodium globostellatate B

C33H47NaO7 (578.3219)

An organic sodium salt that is the monosodium salt of globostellatic acid B. Isolated from the marine sponge Stelletta globostellata, it exhibits cytotoxicity against P-388 murine leukemia cells.

sodium globostellatate C

C33H47NaO7 (578.3219)

An organic sodium salt that is the monosodium salt of globostellatic acid C. Isolated from the marine sponge Stelletta globostellata, it exhibits cytotoxicity against P-388 murine leukemia cells.

tigogenin 3-O-beta-D-glucopyranoside

C33H54O8 (578.3818)

buxalongifolamidine

C35H50N2O5 (578.372)

A natural product found in Buxus natalensis and Buxus longifolia.

tomatidine 3-O-beta-D-glucopyranoside

C33H56NO7+ (578.4057)

S-[(2E,6E,10E)-geranylgeranyl]-L-glutathione

C30H48N3O6S- (578.3264)

[(1R,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate

C34H46N2O6 (578.3356)

WURCS=2.0/1,1,0/[hx12xh_3-6_1*OCCOCCCCCCCCCCCCCCCC/6=O_2*OCCO_4*OCCO_5*OCCO]/1

C30H58O10 (578.403)

2-[[(2R)-3-[(Z)-hexadec-1-enoxy]-2-(5-oxopentanoyloxy)propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C29H57NO8P+ (578.3822)

NAGlySer 16:3/11:0

C32H54N2O7 (578.3931)

NAGlySer 11:0/16:3

C32H54N2O7 (578.3931)

2,3-dihydroxypropyl [2-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propyl] hydrogen phosphate

C30H59O8P (578.3947)

PE-Cer 13:1;2O/14:0;O

C29H59N2O7P (578.406)

PE-Cer 15:0;2O/12:1;O

C29H59N2O7P (578.406)

PE-Cer 12:1;2O/15:0;O

C29H59N2O7P (578.406)

PE-Cer 15:1;2O/12:0;O

C29H59N2O7P (578.406)

PE-Cer 14:0;2O/13:1;O

C29H59N2O7P (578.406)

PE-Cer 12:0;2O/15:1;O

C29H59N2O7P (578.406)

PE-Cer 14:1;2O/13:0;O

C29H59N2O7P (578.406)

PE-Cer 13:0;2O/14:1;O

C29H59N2O7P (578.406)

PEtOH 25:0

C30H59O8P (578.3947)

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C37H54O5 (578.3971)

PMeOH 13:0_13:0

C30H59O8P (578.3947)

PMeOH 12:0_14:0

C30H59O8P (578.3947)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C28H51O10P (578.322)

[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C28H51O10P (578.322)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C28H51O10P (578.322)

[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C28H51O10P (578.322)

[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C28H51O10P (578.322)

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) icosanoate

C30H59O8P (578.3947)

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) docosanoate

C30H59O8P (578.3947)

(1-Butanoyloxy-3-phosphonooxypropan-2-yl) tricosanoate

C30H59O8P (578.3947)

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) octadecanoate

C30H59O8P (578.3947)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C28H51O10P (578.322)

(1-Acetyloxy-3-phosphonooxypropan-2-yl) pentacosanoate

C30H59O8P (578.3947)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C28H51O10P (578.322)

(1-Phosphonooxy-3-propanoyloxypropan-2-yl) tetracosanoate

C30H59O8P (578.3947)

[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C28H51O10P (578.322)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C28H51O10P (578.322)

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) henicosanoate

C30H59O8P (578.3947)

[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C28H51O10P (578.322)

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) nonadecanoate

C30H59O8P (578.3947)

(1-Dodecanoyloxy-3-phosphonooxypropan-2-yl) pentadecanoate

C30H59O8P (578.3947)

(1-Phosphonooxy-3-tridecanoyloxypropan-2-yl) tetradecanoate

C30H59O8P (578.3947)

(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) hexadecanoate

C30H59O8P (578.3947)

(1-Decanoyloxy-3-phosphonooxypropan-2-yl) heptadecanoate

C30H59O8P (578.3947)

[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium

C33H56NO7+ (578.4057)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] hexadecanoate

C30H59O8P (578.3947)

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C37H54O5 (578.3971)

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoate

C37H54O5 (578.3971)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] heptadecanoate

C30H59O8P (578.3947)

[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium

C33H56NO7+ (578.4057)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] hexadecanoate

C30H59O8P (578.3947)

2-[[3-butanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C29H57NO8P+ (578.3822)

2-[[3-hexanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C29H57NO8P+ (578.3822)

[1-carboxy-3-[3-heptanoyloxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C33H56NO7+ (578.4057)

2-[[2-[(Z)-hexadec-9-enoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C29H57NO8P+ (578.3822)

2-[[3-acetyloxy-2-[(Z)-nonadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C29H57NO8P+ (578.3822)

[1-carboxy-3-[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-pentanoyloxypropoxy]propyl]-trimethylazanium

C33H56NO7+ (578.4057)

2-[hydroxy-[3-octanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C29H57NO8P+ (578.3822)

[1-carboxy-3-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-propanoyloxypropoxy]propyl]-trimethylazanium

C33H56NO7+ (578.4057)

2-[[3-heptanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C29H57NO8P+ (578.3822)

2-[hydroxy-[2-[(Z)-octadec-9-enoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C29H57NO8P+ (578.3822)

(25S)-5β-spirostan-3β-yl β-D-glucoside

C33H54O8 (578.3818)

1-dodecanoyl-2-pentadecanoyl-glycero-3-phosphate

C30H59O8P (578.3947)

1-tridecanoyl-2-tetradecanoyl-glycero-3-phosphate

C30H59O8P (578.3947)

TG(34:9)

C37H54O5 (578.3971)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

MGDG O-21:0;O

C30H58O10 (578.403)

MGDG O-23:6

C32H50O9 (578.3455)

MGMG 23:6

C32H50O9 (578.3455)

PA O-18:0/7:3;O3

C28H51O10P (578.322)

PA O-18:0/8:2;O2

C29H55O9P (578.3584)

PA O-18:0/9:1;O

C30H59O8P (578.3947)

PA O-25:3;O3

C28H51O10P (578.322)

PA O-26:2;O2

C29H55O9P (578.3584)

PA O-27:1;O

C30H59O8P (578.3947)

PA P-18:0/7:2;O3

C28H51O10P (578.322)

PA P-18:0/8:1;O2

C29H55O9P (578.3584)

PA 16:1/9:1;O2

C28H51O10P (578.322)

PA 18:0/7:2;O2

C28H51O10P (578.322)

PA 18:0/8:1;O

C29H55O9P (578.3584)

PA 20:1/5:1;O2

C28H51O10P (578.322)

PA 22:0/4:1;O

C29H55O9P (578.3584)

PA 25:2;O2

C28H51O10P (578.322)

PA 26:1;O

C29H55O9P (578.3584)

PA 10:0_17:0

C30H59O8P (578.3947)

PA 11:0_16:0

C30H59O8P (578.3947)

PA 12:0_15:0

C30H59O8P (578.3947)

PA 13:0_14:0

C30H59O8P (578.3947)

PA 23:0/4:0

C30H59O8P (578.3947)

PA 25:0/2:0

C30H59O8P (578.3947)

PG O-22:3;O

C28H51O10P (578.322)

PG P-16:0/6:2;O

C28H51O10P (578.322)

PG P-18:1/4:1;O

C28H51O10P (578.322)

PG 18:1/4:1

C28H51O10P (578.322)

PG 18:2/4:0

C28H51O10P (578.322)

PG 20:2/2:0

C28H51O10P (578.322)

PG 22:2

C28H51O10P (578.322)

LPEth 27:7

C32H51O7P (578.3372)

LPM 28:7

C32H51O7P (578.3372)

PEth 24:1;O

C29H55O9P (578.3584)

PEth 25:0

C30H59O8P (578.3947)

PM 25:1;O

C29H55O9P (578.3584)

PM 26:0

C30H59O8P (578.3947)

CerPE 12:0;O2/15:1;O

C29H59N2O7P (578.406)

CerPE 14:1;O2/13:0;O

C29H59N2O7P (578.406)

CerPE 15:1;O2/12:0;O

C29H59N2O7P (578.406)

CerPE 16:1;O2/11:0;O

C29H59N2O7P (578.406)

CerPE 17:1;O2/10:0;O

C29H59N2O7P (578.406)

CerPE 27:1;O2;O

C29H59N2O7P (578.406)

SM 14:1;O2/10:0;O

C29H59N2O7P (578.406)

SM 24:1;O2;O

C29H59N2O7P (578.406)

Trp-CDCA

C35H50N2O5 (578.372)

Trp-DCA

C35H50N2O5 (578.372)

Trp-HDCA

C35H50N2O5 (578.372)

Trp-UDCA

C35H50N2O5 (578.372)

ST 26:2;O3;GlcA

C32H50O9 (578.3455)

ST 27:1;O2;GlcA

C33H54O8 (578.3818)

ST 29:7;O;GlcA

C35H46O7 (578.3243)

ST 26:3;O4;Hex

C32H50O9 (578.3455)

ST 27:2;O3;Hex

C33H54O8 (578.3818)

(17z,19z,21z,23z,25z)-4,6,10,12,14,16-hexahydroxy-28-isopropyl-3,15,27-trimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one

C33H54O8 (578.3818)

(1r,3ar,5r,5ar,5br,7ar,9s,11as,11br,12r,13ar,13bs)-5,9-dihydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-12-yl 4-hydroxybenzoate

C37H54O5 (578.3971)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13's,16's,18's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]oxy]oxane-3,4,5-triol

C33H54O8 (578.3818)

2-[(2s,4as,8s,8as)-8-{[(2s,3r,4r)-2-(2h-1,3-benzodioxol-5-yl)-4-(2h-1,3-benzodioxol-5-ylmethyl)oxolan-3-yl]methoxy}-4a,8-dimethyl-octahydronaphthalen-2-yl]propan-2-ol

C35H46O7 (578.3243)

(2s,3r,4s,5r)-2-{[(1s,4r,5r,6r,8r,10s,12s,13s,15s,16r,18s,21r)-8-ethoxy-15-hydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan-18-yl]oxy}oxane-3,4,5-triol

C33H54O8 (578.3818)

4,6,10,12,14,16-hexahydroxy-28-isopropyl-3,15,27-trimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one

C33H54O8 (578.3818)

(4ar,5s,6r,8ar)-5-{2-[1-(4-{[(2e)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}butyl)-5-oxo-2h-pyrrol-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

C34H46N2O6 (578.3356)

(3s,4r,6r,10s,12s,14s,15s,16s,17e,19e,21e,23e,25e,27r,28s)-4,6,10,12,14,16-hexahydroxy-28-isopropyl-3,15,27-trimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one

C33H54O8 (578.3818)

(1s,2s,3s,4r,5r,6r)-2,3,4,5-tetrahydroxy-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}cyclohexyl (9s)-9-methylheptadecanoate

C29H54O11 (578.3666)

(2s)-2-(3-hydroxy-8,8-dimethyl-1,4-dioxo-6,7-dihydro-5h-phenanthren-2-yl)propyl (9z)-octadec-9-enoate

C37H54O5 (578.3971)

methyl (1r,2r,4ar,4br,5s,6as,9r,10r,10as,10br,12ar)-5,10-dihydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-dodecahydro-2h-chrysene-6a-carboxylate

C33H54O8 (578.3818)

(1ar,2r,3s,3as,5r,6r,7ar,7bs)-2-[(2e)-but-2-en-2-yl]-6-hydroxy-1a,6-dimethyl-3-[(1e,3e)-4-[(4s,5s)-2,2,5-trimethyl-1,3-dioxan-4-yl]penta-1,3-dien-1-yl]-octahydronaphtho[1,2-b]oxiren-5-yl 2-phenylacetate

C36H50O6 (578.3607)

(25S)-5β-sprostane-3β-ol-3-O-β-D-glucopyranoside

C33H54O8 (578.3818)

{"Ingredient_id": "HBIN004790","Ingredient_name": "(25S)-5\u03b2-sprostane-3\u03b2-ol-3-O-\u03b2-D-glucopyranoside","Alias": "NA","Ingredient_formula": "C33H54O8","Ingredient_Smile": "CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)CO)O)O)O)C)C)C)OC1","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "38986","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13's,16's,18's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]oxy]oxane-3,4,5-triol

C33H54O8 (578.3818)

(1r,2s,3s,4r,5s,6r)-2,3,4,5-tetrahydroxy-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}cyclohexyl 16-methylheptadecanoate

C29H54O11 (578.3666)

6-{5-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxy-3-methoxy-2-(3-methylbut-2-en-1-yl)phenoxy}-2-hydroxy-4-methoxy-3-(3-methylbut-2-en-1-yl)benzoic acid

C35H46O7 (578.3243)

6-[5-(3,7-dimethylocta-2,6-dien-1-yl)-4-hydroxy-3-methoxy-2-(3-methylbut-2-en-1-yl)phenoxy]-2-hydroxy-4-methoxy-3-(3-methylbut-2-en-1-yl)benzoic acid

C35H46O7 (578.3243)

(2r,3r,4s,5s,6r)-3,5-bis(acetyloxy)-2-(hydroxymethyl)-6-[(2r,3s)-2,3,4-trihydroxybutoxy]oxan-4-yl tetradecanoate

C28H50O12 (578.3302)

n-[(1r,5r,6r,8r,9s,11s,12s,15s,16r,18s)-9-(acetyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-5-hydroxy-7,7,12,16-tetramethyl-19-oxapentacyclo[9.8.0.0¹,¹⁸.0³,⁸.0¹²,¹⁶]nonadec-3-en-6-yl]benzenecarboximidic acid

C35H50N2O5 (578.372)

6-hydroxy-2,4,4-trimethyl-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e,19e,21e,23e)-3,7,12,16,20-pentamethyl-25-oxohexacosa-1,3,5,7,9,11,13,15,17,19,21,23-dodecaen-1-yl]cyclohex-2-en-1-one

C40H50O3 (578.376)

methyl (1r,2r,4ar,4br,6as,7s,9r,10r,10as,10br,12ar)-7,10-dihydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-dodecahydro-2h-chrysene-6a-carboxylate

C33H54O8 (578.3818)

(1s,2s,3r,4z,6z,10s,12z,14z)-10-[(5s,6r,7r,8s,9s)-5,7-dihydroxy-9-methoxy-6,8-dimethyldecan-2-yl]-2,17-dihydroxy-3,5,7-trimethyl-9,19-dioxabicyclo[16.1.0]nonadeca-4,6,12,14-tetraen-8-one

C33H54O8 (578.3818)

(4as,5r,6s,8as)-5-{2-[1-(4-{[(2e)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}butyl)-2-oxo-5h-pyrrol-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

C34H46N2O6 (578.3356)

(3r,4s,5r,6s)-6-{[(1r,3r,3ar,5ar,6r,7s,9as,11ar)-3,6-dihydroxy-1-[(2r,5s)-5-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-5-methoxyoxane-3,4-diol

C33H54O8 (578.3818)

2-{[2-(2-{[1,2-dihydroxy-3-(methylamino)decylidene]amino}-n-methylpropanamido)-1-hydroxy-4-methylpentylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C30H50N4O7 (578.3679)

({20-hydroxy-8,13,14,17-tetramethoxy-4,10,12,16-tetramethyl-3,22-dioxo-2-azabicyclo[16.3.1]docosa-4,6,10,18-tetraen-9-yl}oxy)methanimidic acid

C30H46N2O9 (578.3203)

5,9-dihydroxy-8-(3-hydroxy-4-methylhexan-2-yl)-2-(2-hydroxypropan-2-yl)-9-methoxy-4a,10a-dimethyl-7-(2-oxopropyl)-2,3,4,4b,5,11,12,12a-octahydro-1,10-dioxatetraphen-6-one

C32H50O9 (578.3455)

2-(but-2-en-2-yl)-6-hydroxy-1a,6-dimethyl-3-[4-(2,2,5-trimethyl-1,3-dioxan-4-yl)penta-1,3-dien-1-yl]-octahydronaphtho[1,2-b]oxiren-5-yl 2-phenylacetate

C36H50O6 (578.3607)

3,5,5-trimethyl-4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-3-ene-1,2-dione

C40H50O3 (578.376)

(2r,4ar,4bs,5s,9r,10ar,12ar)-5,9-dihydroxy-8-[(2s,3r,4s)-3-hydroxy-4-methylhexan-2-yl]-2-(2-hydroxypropan-2-yl)-9-methoxy-4a,10a-dimethyl-7-(2-oxopropyl)-2,3,4,4b,5,11,12,12a-octahydro-1,10-dioxatetraphen-6-one

C32H50O9 (578.3455)

(1r,3ar,5as,6s,7s,9ar,9br,11ar)-1-[(2s,3r,5r)-5-ethyl-3-hydroxy-6-methylheptan-2-yl]-3a-hydroxy-6,9a,11a-trimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate

C37H54O5 (578.3971)

n-[(3s,6s,7s,8s,11r,12s,14r,15s,16r)-14-(acetyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-3-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),4-dien-6-yl]benzenecarboximidic acid

C35H50N2O5 (578.372)

1-(5-ethyl-3-hydroxy-6-methylheptan-2-yl)-3a-hydroxy-6,9a,11a-trimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate

C37H54O5 (578.3971)

6-hydroxy-3-[(3e,5e,7e,9e)-18-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

C40H50O3 (578.376)

(2r,3s,4s,5r,6r)-2-methyl-6-[(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's,18's,19's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-oloxy]oxane-3,4,5-triol

C33H54O8 (578.3818)

2-methyl-6-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-oloxy}oxane-3,4,5-triol

C33H54O8 (578.3818)

(1r,6s,7s,8r,11r,12s,14r,15s,16r)-15-[(1s)-1-(dimethylamino)ethyl]-7-(hydroxymethyl)-7,12,16-trimethyl-6-(n-methylbenzamido)tetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadec-3-en-14-yl acetate

C36H54N2O4 (578.4083)

n-[(1s,3r,4s,6r,7s,8r,13r,16s,17s,20r)-6-(acetyloxy)-7-[(1r)-1-(dimethylamino)ethyl]-13-hydroxy-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icos-10-en-16-yl]benzenecarboximidic acid

C35H50N2O5 (578.372)

(17e,19e,21e,23e,25e)-4,6,10,12,14,16-hexahydroxy-3,15,27-trimethyl-28-propyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one

C33H54O8 (578.3818)

2-{[7,10-dihydroxy-1-(3-hydroxy-6-methylhept-5-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-6-methyloxane-3,4,5-triol

C33H54O8 (578.3818)

2-(8-{[2-(2h-1,3-benzodioxol-5-yl)-4-(2h-1,3-benzodioxol-5-ylmethyl)oxolan-3-yl]methoxy}-4a,8-dimethyl-octahydronaphthalen-2-yl)propan-2-ol

C35H46O7 (578.3243)

5-{2-[1-(4-{[1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}butyl)-5-oxo-2h-pyrrol-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

C34H46N2O6 (578.3356)

(2r,3r,4r,5r,6s)-2-{[(1r,2s,3as,3bs,7s,9ar,9bs,10s,11as)-7,10-dihydroxy-1-[(2s,3s)-3-hydroxy-6-methylhept-5-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-6-methyloxane-3,4,5-triol

C33H54O8 (578.3818)

(1s,2r,4e,7s,10e,12e,14r,15s,16s)-7-[(2s,4e,7s,8r,9r,10s,11s)-7,9-dihydroxy-11-methoxy-8,10-dimethyldodec-4-en-2-yl]-2,15-dihydroxy-10,12,14-trimethyl-8,17-dioxabicyclo[14.1.0]heptadeca-4,10,12-trien-9-one

C33H54O8 (578.3818)

3,5-bis(acetyloxy)-2-(hydroxymethyl)-6-(2,3,4-trihydroxybutoxy)oxan-4-yl tetradecanoate

C28H50O12 (578.3302)

(4ar,5s,6r,8ar)-5-{2-[1-(4-{[(2e)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}butyl)-2-oxo-5h-pyrrol-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

C34H46N2O6 (578.3356)

2-(hydroxymethyl)-6-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]oxy}oxane-3,4,5-triol

C33H54O8 (578.3818)

methyl (1's,1as,3'e,4ar,5s,6'r,7ar,7bs,9'e,12's,19's)-19'-hydroxy-3,3,4'-trimethyl-2',8'-dioxo-12'-(prop-1-en-2-yl)-1a,2,4,4a,6,7,7a,7b-octahydro-1h-7',15'-dioxaspiro[cyclopropa[e]azulene-5,16'-tricyclo[12.3.1.1⁶,⁹]nonadecane]-3',9',14'(18')-triene-18'-carboxylate

C35H46O7 (578.3243)

(1r,3as,5as,6s,7s,9ar,9br,11ar)-1-[(2s,3r,5r)-5-ethyl-3-hydroxy-6-methylheptan-2-yl]-3a-hydroxy-6,9a,11a-trimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate

C37H54O5 (578.3971)

3-(docosyloxy)-1,8-dihydroxy-6-methylanthracene-9,10-dione

C37H54O5 (578.3971)

(2s,3r,4s,5r)-2-{[(1s,4r,5s,6r,8r,10s,12s,13s,15s,16r,18s,21r)-8-ethoxy-15-hydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan-18-yl]oxy}oxane-3,4,5-triol

C33H54O8 (578.3818)

(1r,2s,3ar,4s,5ar,6s,7s,8s,10as,10br)-2,8-bis(acetyloxy)-6-(butanoyloxy)-7-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-4-yl butanoate

C32H50O9 (578.3455)

5-{2-[1-(4-{[1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}butyl)-2-oxo-5h-pyrrol-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

C34H46N2O6 (578.3356)

(1s,2r,5r,7r,10s,14r,15r,16r,20r,25s,28r)-7,14,28-trihydroxy-6,6,10,14,21,21,25,28-octamethylheptacyclo[14.10.2.0²,¹¹.0²,¹⁵.0⁵,¹⁰.0¹⁷,²⁶.0²⁰,²⁵]octacosa-11,17(26)-diene-13,22,27-trione

C36H50O6 (578.3607)

(1r,3ar,5as,6s,7s,9ar,9br,11ar)-1-[(2s,3r,5r)-5-ethyl-3-hydroxy-6-methylheptan-2-yl]-6,9a,11a-trimethyl-5-oxo-1h,2h,3h,3ah,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl 4-hydroxybenzoate

C37H54O5 (578.3971)

(1r,2s,3ar,4s,5ar,6s,7s,8s,10ar,10bs)-4,7-bis(acetyloxy)-6-(butanoyloxy)-8-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-2-yl butanoate

C32H50O9 (578.3455)

2-(2-{2-[(3-amino-1,2-dihydroxydecylidene)amino]-n-methylpropanamido}-3-(4-hydroxyphenyl)-n-methylpropanamido)-4-methylpentanoic acid

C30H50N4O7 (578.3679)

n-[(3r,6s,7s,8s,11r,12s,14r,15s,16r)-14-(acetyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-3-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),4-dien-6-yl]benzenecarboximidic acid

C35H50N2O5 (578.372)

2-(3-hydroxy-8,8-dimethyl-1,4-dioxo-6,7-dihydro-5h-phenanthren-2-yl)propyl octadec-9-enoate

C37H54O5 (578.3971)

n-[14-(acetyloxy)-15-[1-(dimethylamino)ethyl]-3-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),4-dien-6-yl]benzenecarboximidic acid

C35H50N2O5 (578.372)

(1r,3ar,5s,5ar,5br,7ar,9s,11as,11br,12r,13ar,13br)-5,9-dihydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-12-yl 4-hydroxybenzoate

C37H54O5 (578.3971)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13's,16's,18'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]oxy]oxane-3,4,5-triol

C33H54O8 (578.3818)

(1r,2s,3ar,4s,5ar,6s,7s,8s,10ar,10bs)-2,8-bis(acetyloxy)-6-(butanoyloxy)-7-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-4-yl butanoate

C32H50O9 (578.3455)

(1r,2s,3ar,4s,5ar,6s,7s,8s,10ar,10bs)-4,8-bis(acetyloxy)-6-(butanoyloxy)-7-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-2-yl butanoate

C32H50O9 (578.3455)

(4z)-4-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyl-2-oxooctadeca-3,5,7,9,11,13,15-heptaen-17-yn-1-ylidene]-3,5,5-trimethylcyclohex-2-en-1-one

C40H50O3 (578.376)

n-[6-(acetyloxy)-7-[1-(dimethylamino)ethyl]-13-hydroxy-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icos-10-en-16-yl]benzenecarboximidic acid

C35H50N2O5 (578.372)

(1r,2s,3ar,4s,5ar,6s,7s,8s,10as,10br)-4,7-bis(acetyloxy)-6-(butanoyloxy)-8-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-2-yl butanoate

C32H50O9 (578.3455)

(2r,3s,4s,5r,6r)-2-methyl-6-[(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,16's,18's,19's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-oloxy]oxane-3,4,5-triol

C33H54O8 (578.3818)

(1r,2r,3r,4e,6e,10s,12e,14e,17r,18r)-10-[(2s)-5,7-dihydroxy-9-methoxy-6,8-dimethyldecan-2-yl]-2,17-dihydroxy-3,5,7-trimethyl-9,19-dioxabicyclo[16.1.0]nonadeca-4,6,12,14-tetraen-8-one

C33H54O8 (578.3818)

4-[(3e,5e,7e,9e)-18-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyl-2-oxooctadeca-3,5,7,9,11,13,15-heptaen-17-yn-1-ylidene]-3,5,5-trimethylcyclohex-2-en-1-one

C40H50O3 (578.376)

(2r)-2-[(2r,3r)-2-[(2r)-2-{[(2r,3r)-3-amino-1,2-dihydroxyoctylidene]amino}-n,3-dimethylbutanamido]-n,3-dimethylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C30H50N4O7 (578.3679)

{[(1r,2s,3e,5s,6s,10s,18r,19s,21s)-10,11,15-trihydroxy-6,18,21-trimethoxy-2,4,10,19-tetramethyl-8-methylidene-22-oxa-12-azatricyclo[11.8.2.0¹⁷,²³]tricosa-3,11,13(23),16-tetraen-5-yl]oxy}methanimidic acid

C30H46N2O9 (578.3203)

6-hydroxy-2,4,4-trimethyl-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohexa-2,5-dien-1-one

C40H50O3 (578.376)

(1r,2s,3ar,4s,5ar,6s,7s,8s,10as,10br)-4,8-bis(acetyloxy)-6-(butanoyloxy)-7-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-2-yl butanoate

C32H50O9 (578.3455)

2-({8-ethoxy-15-hydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan-18-yl}oxy)oxane-3,4,5-triol

C33H54O8 (578.3818)

n-[9-(acetyloxy)-15-[1-(dimethylamino)ethyl]-5-hydroxy-7,7,12,16-tetramethyl-19-oxapentacyclo[9.8.0.0¹,¹⁸.0³,⁸.0¹²,¹⁶]nonadec-3-en-6-yl]benzenecarboximidic acid

C35H50N2O5 (578.372)

1-(5-ethyl-3-hydroxy-6-methylheptan-2-yl)-6,9a,11a-trimethyl-5-oxo-1h,2h,3h,3ah,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl 4-hydroxybenzoate

C37H54O5 (578.3971)

(2s)-2-[(2s,3s)-2-[(2s)-2-{[(2s,3s)-3-amino-1,2-dihydroxyoctylidene]amino}-n,3-dimethylbutanamido]-n,3-dimethylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C30H50N4O7 (578.3679)

5,9-dihydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-12-yl 4-hydroxybenzoate

C37H54O5 (578.3971)

(2r,3r,4r,5r,6s)-2-{[(1r,2s,3as,3bs,7s,9ar,9bs,10r,11as)-7,10-dihydroxy-1-[(2s,3s)-3-hydroxy-6-methylhept-5-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-6-methyloxane-3,4,5-triol

C33H54O8 (578.3818)

3,5,5-trimethyl-4-[(1e,3e,5e,7e,9e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-3-ene-1,2-dione

C40H50O3 (578.376)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13's,16's,18'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]oxy]oxane-3,4,5-triol

C33H54O8 (578.3818)

2-(2-{2-[(3-amino-1,2-dihydroxyoctylidene)amino]-n,3-dimethylbutanamido}-n,3-dimethylpentanamido)-3-(4-hydroxyphenyl)propanoic acid

C30H50N4O7 (578.3679)

{[(1r,8s,9s,12s,13r,14s,16s,17r,20s)-20-hydroxy-8,13,14,17-tetramethoxy-4,10,12,16-tetramethyl-3,22-dioxo-2-azabicyclo[16.3.1]docosa-4,6,10,18-tetraen-9-yl]oxy}methanimidic acid

C30H46N2O9 (578.3203)